Search Results - "Lobato matilla, M E"

4CPS-329 Do patients with immune mediated inflammatory diseases think they know their medication? by Melgarejo-Ortuño, A, Romero Jiménez, RM, Chamorro De Vega, E, Ais Larisgoitia, A, Lobato Matilla, ME, García Sánchez, S, Narrillos Moraza, A, Herranz Alonso, A, Sanjurjo Saez, M

“…Background and importancePatients with immune mediated inflammatory diseases (IMID) have complex treatment. This is due to biological treatments, other chronic…”
Get full text

P646 Clinical decision support in the prevention of adverse effects associated with immunosuppressive drugs in patients with Inflammatory Bowel Disease by Lobato Matilla, M E, Marin Jimenez, I, Menchén Viso, L A, Miranda Bautista, J, Chamorro de Vega, E, Romero Jiménez, R, Ferris Villanueva, M, Herranz Alonso, A, Sanjurjo Sáez, M

“…Abstract Background With the goal of effective and early prevention and detection of medication-related adverse effects, an explosion of technological advances…”
Get full text

P523 Effectiveness of biological treatments for inflammatory bowel disease in the elderly patients by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Ballester, M P, Baston Rey, I, Castaño Garcia, A, Miranda Bautista, J, Saiz Chumillas, R, Benitez, J M, Sanchez Delgado, L, Lopez-Garcia, A, Rubin de Celix, C, Martin-Arranz, M D, Lopez Sanroman, A, Fernandez-Clotet, A, Merino Murgui, V, Calviño Suarez, C, Florez, P, Lobato Matilla, M E, Sicilia, B, Soto Escribano, P, Maroto Martin, C, Alonso Abreu, I, Melcarne, L, Elena, P G, Iyo, E, Elosua Gonzalez, A, Saiz, E, Hernandez Villalba, L, Perez Galindo, P, Torrealba Medina, L, Monsalve Alonso, S, Olmos Jerez, J A, Dueñas Sadornil, C, Barreiro-De Acosta, M

“…Abstract Background Biological treatments used for the treatment of inflammatory bowel disease (IBD) have demonstrated their efficacy and safety, although…”
Get full text

P410 Safety of biological drugs for inflammatory bowel disease in elderly patients by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Ballester, M P, Baston Rey, I, Castaño Garcia, A, Miranda Bautista, J, Saiz Chumillas, R, Benitez, J M, Sanchez Delgado, L, Lopez-Garcia, A, Rubin de Celix, C, Lopez Sanroma, A, Martin-Arranz, M D, Fernández-Clotet, A, Merino Murgui, V, Calviño Suárez, C, Florez, P, Lobato matilla, M E, Sicilia, B, Soto Escribano, P, Maroto Martin, C, Alonso Abreu, I, Melcarne, L, Plaza Santos, R, Marques Cami, M, Caballero Mateos, A, Gómez Díez, C, Calafat, M, Alonso Galan, H, Vega Villaamil, P, Castro Senosiain, B, Guerro Moya, A, Rodriguez Diaz, C Y, Spicakova, K, Manceñido Marcos, N, Molina, G, De Castro, L, Mañosa Ciria, M, Barreiro-De Acosta, M

“…Abstract Background The most feared adverse events related to biological treatment in patients with inflammatory bowel disease (IBD) are the development of…”
Get full text

5PSQ-085 Metabolic disorders in patients treated with second-generation antipsychotics: an opportunity for pharmaceutical intervention by Melgarejo-Ortuño, A, Lobato-Matilla, ME, Revuelta-Herrero, JL, De Lorenzo-Pinto, A, García-González, X, García-Martín, E, Amor-García, MA, García-Sánchez, S, Martínez-Ortega, PA, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundSecond-generation antipsychotics (SGAs) have improved the treatment of psychiatric disorders. Nevertheless, their use is associated with the…”
Get full text

CP-096 Final results of effectiveness and safety of direct acting antiviral agents in the treatment of chronic hepatitis c virus infection by Chamorro-De-Vega, E, Gimenez-Manzorro, A, Gomez-Marquez, AM, Monje-Garcia, B, Escudero-Vilaplana, V, Lallana-Sainz, E, Lobato-Matilla, ME, Revuelta-Herrero, JL, Herranz-Alonso, A, Sanjurjo-Saez, M

“…BackgroundDirect acting antivirals (DAAs) have become elective treatment for chronic hepatitis C virus (HCV) infection but final data regarding routine medical…”
Get full text